Tryptophan, mood, and cognitive function

Brain, Behavior, and Immunity

Volumn 16, Issue 5, 2002, Pages 581-589

  Riedel, Wim J ^a,b   Klaassen, Tineke ^a   Schmitt, Jeroen A J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Affective disorder; Amino acids; Attention; Cognition; Memory; Mood; Serotonergic vulnerability; Tryptophan depletion

Indexed keywords

AMINO ACID MIXTURE; ANTIDEPRESSANT AGENT; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRYPTOPHAN;

ATTENTION; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DRUG EFFECT; FAMILY HISTORY; FRONTAL CORTEX; HUMAN; LEARNING; MAJOR DEPRESSION; MEMORY CONSOLIDATION; MOOD; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN SYNTHESIS; RATING SCALE; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM; SIDE EFFECT; TASK PERFORMANCE; TREATMENT OUTCOME; WORD RECOGNITION; AFFECT; DEPRESSION; MEMORY; MEMORY DISORDER; METABOLISM; REVIEW;

AFFECT; ATTENTION; COGNITION; COGNITION DISORDERS; DEPRESSIVE DISORDER; HUMANS; MEMORY; MEMORY DISORDERS; MOOD DISORDERS; SEROTONIN; TRYPTOPHAN;

EID: 0036429005     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(02)00013-2     Document Type: Conference Paper

References (49)

1. Allain, H., Lieuiy, A., Brunet, B. F., Mirabaud, C., Trebon, P., LeCoz, F., & Gandon, J. M. (1992). Antidepressants and cognition: Comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacol. Suppl., 106, 56-61.
2. Benkelfat, C., Ellenbogen, M. A., Dean, P., Palmour, R. M., & Young, S. N. (1994). Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch. Gen. Psychiatry, 51, 687-697.
3. Blier, P., & de Montigny, C. (1994). Current advances and trends in the treatment of depression. Trends Pharmacol. Sci., 15, 220-226.
4. Camilleri, M. (2001). Management of the irritable bowel syndrome. Gastroenterology, 120, 652-668.
5. Capuron, L., Ravaud, A., & Dantzer, R. (2000). Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon α-2b therapy. J. Clin. Oncol., 18, 2143-2151.
6. Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Macs, M., & Dantzer, R. (2002). Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry, 7, 468-473.
7. Carpenter, L. L., Anderson, G. M., Pelton, G. H., Gudin, J. A., Kirwin, P. D., Price, L. H., Heninger, G. R., & McDougle, C. J. (1998). Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology, 19, 26-35.
8. Charney, E. A., & Weissman, M. M. (1988). Epidemiology of depressive and manic syndromes. In A. Georgotas & R. Cancro (Eds.), Depression and Mania (pp. 26-52). New York: Elsevier.
9. Cowen, P. J., Clifford, E. M., Walsh, A. E. S., Williams, C., & Fairbum, C. G. (1996). Moderate dieting causes 5-HT(2C) receptor supersensitivity. Psychol. Med., 26, 1155-1159.
10. Danjou, P., Hamon, M., Lacomblez, L., & Warot, D., et al. (1990). Psychomotor, subjective and neuroendocrine effects of acute tryptophan depletion in the healthy volunteer. Psychiatr. Psychobiol., 5, 31-38.
11. Delgado, P. L., Charney, D. S., Price, L. H., Landis, H., & Heninger, G. R. (1989). Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci., 45, 2323-2332.
12. Delgado, P. L., Price, L. H., Miller, H. L., Salomon, R. M., Licinio, J., Krystal, J. H., Heninger, G. R., & Charney, D. S. (1991). Rapid serotonin depletion as a provocative challenge test for patients with major depression: Relevance to antidepressant action and the neurobiology of depression. Psychopharmacol. Bull., 27, 321-330.
13. Ellenbogen, M. A., Young, S. N., Dean, P., Palmour, R. N., & Benkelfat, C. (1996). Mood response to acute tryptophan depletion in healthy volunteers: Sex differences and temporal stability. Neuropsychopharmacology, 15, 465-474.
14. Fudge, J. L., Perry, P. J., Garvey, M. J., & Kelly, M. W. (1990). A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients. J. Affect. Disord., 18, 275-280.
15. Jacobs, B. L., Praag, H., & Gage, F. H. (2000). Adult brain neurogenesis and psychiatry: A novel theory of depression. Mol. Psychiatry, 5, 262-269.
16. Kimura, D., & D'Amico, C. (1989). Evidence for subgroups of adextrals based on speech lateralization and cognitive patterns. Neuropsychologia, 27, 977-986.
17. Klaassen, T., Riedel, W. J., Deutz, N. E. P., Van Someren, A., & Van Praag, H. M. (1999a). Specificity of the tryptophan depletion method. Psychopharmacology, 141, 279-286.
18. Klaassen, T., Riedel, W. J., Honig, A., Van Someren, A., Deutz, N. E. P., & Van Praag, H. M. (1999b). Mood effects of 24-hour tryptophan depletion in healthy first degree relatives of patients with affective disorders. Biol. Psychiatry, 46, 489-497.
19. Lam, R. W., Zis, A. P., Grewal, A., Delgado, P. L., Charney, D. S., & Krystal, J. H. (1996). Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch. Gen. Psychiatry, 53, 41-44.
20. Lembo, T. (2000). Neurotransmitter antagonism in management of irritable bowel syndrome. Lancet, 355, 1030-1031.
21. Maes, M., Jacobs, M. P., Suy, E., Vandewoude, M., Minner, B., & Raus, J. (1990). Effects of dexamethasone on the availability of L-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients. Biol. Psychiatry, 27, 854-862.
22. Maes, M., & Meltzer, H. Y. (1995). The serotonin hypothesis of major depression. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress (pp. 933-944). New York: Raven Press.
23. Markus, C. R. (1999). Relations between Stress, Food and Mood: A Role for Brain Serotonin. Utrecht: Elinkwijk.
24. McAllister-Williams, R. H., Ferrier, I. N., & Young, A. H. (1998). Mood and neuropsychological function in depression: The role of corticosteroids and serotonin. Psychol. Med., 28, 573-584.
25. Nishizawa, S., Benkelfat, C., Young, S. N., Leyton, M., Mzengeza, S., de Montigny, C., Blier, P., & Diksic, M. (1997). Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sci. USA, 94, 5308-5313.
26. Normann, C. (2000). Towards a new model for cellular pathophysiology in affective disorder. Acta Neuropsychiatr., 12, 77-80.
27. 2+ channels. J. Neurosci., 20, 8290-8297.
28. O'Hanlon, J., Robbe, H. W. J., Vermeeren, A., Van-Leeuwen, C., & Danjou, P. E. (1998). Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J. Clin. Psychopharmacol., 18, 212-221.
29. Park, S. B., Coull, J. T., McShane, R. H., Young, A. H., Sahakian, B. J., Robbins, T. W., & Cowen, P. J. (1994). Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology, 33, 575-588.
30. Ramaekers, J. G., Muntjewerff, N. D., & O'Hanlon, J. F. (1995). A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br. J. Clin. Pharmacol., 39, 397-404.
31. Richter-Levin, G., & Segal, M. (1996). Serotonin, aging and cognitive functions of the hippocampus. Rev. Neurosci., 7, 103-113.
32. Riedel, W. J., Klaassen, T., Deutz, N. E. P., Van Someren, A., & Van Praag, H. M. (1999a). Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology, 141, 362-369.
33. Riedel, W. J., Schoenmakers, E., Vermeeren, A., & O'Hanlon, J. F. (1999b). The influence of trazodone treatment on cognitive functions in outpatients with major depressive disorder. Hum. Psychopharmacol., 14, 499-508.
34. Riedel, W. J., Klaassen, T., Griez, E., Honig, A., Menheere, P. P. C. A., & Van Praag, H. M. (2002). Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: Evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology, 26, 358-367.
35. Robbins, T. W. (1997). Arousal systems and attentional processes. Biol. Psychol., 45, 57-71.
36. Rubinsztein, J., Rogers, R. D., Riedel, W. J., Mehta, M. A., Robbins, T. W., & Sahakian, B. J. (2001). Acute dietary tryptophan depletion impairs affective shifting and delayed visual recognition in healthy volunteers. Psychopharmacology, 154, 319-326.
37. Schmitt, J. A., Jorissen, B. L., Sobczak, S., van Boxtel, M. P., Hogervorst, E., Deutz, N. E., & Riedel, W. J. (2000). Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. J. Psychopharmacol., 14, 21-29.
38. Schmitt, J. A. J., Kruizinga, M., & Riedel, W. J. (2001). Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. J. Psychopharmacol., 15, 173-179.
39. Schmitt, J. A. J., Kruizinga, M., Teunisse, S., Van Boxtel, M. P. J., Vuurman, E. F. P. M., & Riedel, W. J. (2002). Additional dopamine reuptake inhibition prevents vigilance decrement induced by serotonergic reuptake inhibition in man. J. Psychopharmacol., 16, 207-214.
40. Siegfried, K., & O'Connolly, M. (1986). Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression. Int. Clin. Psychopharmacol., 1, 231-243.
41. Sirvio, J., Riekkinen, P., Jr., Jakala, P., & Riekkinen, P. J. (1994). Experimental studies on the role of serotonin in cognition. Prog. Neurobiol., 43, 363-379.
42. Smith, K. A., Clifford, E. M., Hockney, R. A., & Clark, D. M. (1997a). Effect of tryptophan depletion on mood in male and female volunteers: A pilot study. Hum.-Psychopharmacol.-Clin.-Exp., 12, 111-117.
43. Smith, K. A., Fairburn, C. G., & Cowen, P. J. (1997b). Relapse of depression after rapid depletion of tryptophan. Lancet, 349, 915-919.
44. Sternberg, S. (1969). Memory scanning: Mental processes revealed by reaction time experiments. Am. Scientist, 57, 421-457.
45. Stokes, P. E. (1995). The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur. Neuropsychopharmacol., 5(Suppl.), 77-82.
46. Stroop, J. R. (1935). Studies of interference in serial verbal reactions. J. Exp. Psychol., 18, 643-662.
47. Van Praag, H. M. (1996). Faulty cortisol/serotonin interplay: Psychopathological and biological characterisation of anew, hypothetical depression subtype (seca depression). Psychiatry Res., 65, 143-157.
48. Weltzin, T. E., Fernstrom, J. D., McConaha, C., & Kaye, W. H. (1994). Acute tryptophan depletion in bulimia: Effects on large neutral amino acids. Biol. Psychiatry, 35, 388-397.
49. Young, S. N., Smith, S. E., Pihl, R. O., & Ervin, F. R. (1985). Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology, 87, 173-177.